A Study of the Gut Microbiome in Patients with Lymphoma or Myeloma, and Undergoing Stem Cell Transplant

Overview

About this study

The purpose of this study is to determine the alterations in the intestinal microbiology in patients after undergoing chemotherapy, diet changes, and the use of antibiotics related to a stem cell transplant for Multiple Myeloma or Lymphoma; and how does this affect the success of the transplant and the patients long-term survival.

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • The Multiple Myeloma study team will be responsible for approaching potential participants

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Peter Bergsagel, M.D.

Closed for enrollment

Contact information:

Peter Bergsagel M.D.

(480) 301-4704

Bergsagel.leif@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Thomas Witzig, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Julianne Lunde M.A.

(507) 266-2657

Lunde.Julianne@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20347031

Mayo Clinic Footer